Oscar Health (NYSE:OSCR) Receives Overweight Rating from Piper Sandler

Piper Sandler reissued their overweight rating on shares of Oscar Health (NYSE:OSCR) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $28.00 price objective on the stock.

Other equities research analysts have also recently issued reports about the stock. Baird R W raised shares of Oscar Health to a strong-buy rating in a research report on Thursday, May 30th. Bank of America reissued a neutral rating and set a $21.00 price objective (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Wells Fargo & Company increased their target price on Oscar Health from $24.00 to $27.00 and gave the stock an overweight rating in a research report on Wednesday, June 12th. Finally, Robert W. Baird began coverage on Oscar Health in a research report on Thursday, May 30th. They set an outperform rating and a $28.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus price target of $24.17.

Oscar Health Stock Up 1.5 %

OSCR stock opened at $20.99 on Tuesday. The company has a 50 day moving average price of $17.18 and a two-hundred day moving average price of $17.29. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market capitalization of $4.98 billion, a P/E ratio of -52.48, a PEG ratio of 33.66 and a beta of 1.61. Oscar Health has a one year low of $4.72 and a one year high of $23.44.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the previous year, the business earned ($0.07) earnings per share. The business’s revenue for the quarter was up 44.6% on a year-over-year basis. As a group, sell-side analysts expect that Oscar Health will post 0.01 EPS for the current year.

Insiders Place Their Bets

In related news, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at approximately $2,530,257.52. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CFO Richard Scott Blackley sold 29,957 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $511,066.42. Following the completion of the transaction, the chief financial officer now directly owns 853,875 shares in the company, valued at $14,567,107.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at approximately $2,530,257.52. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock worth $3,007,069 over the last quarter. 25.11% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Avalon Trust Co acquired a new position in shares of Oscar Health in the first quarter worth about $69,000. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health in the 2nd quarter valued at approximately $78,000. Prevail Innovative Wealth Advisors LLC purchased a new position in shares of Oscar Health during the 4th quarter valued at approximately $92,000. Quest Partners LLC acquired a new stake in shares of Oscar Health during the second quarter worth approximately $93,000. Finally, Amalgamated Bank increased its stake in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.